High-Tech Surgical Tools Hold Promise Despite Complexity – Circulation
This article was originally published in The Gray Sheet
Executive Summary
The surgical community's interest in minimally invasive coronary procedures will continue to provide medical device companies with a wealth of opportunities to develop new, innovative products, according to a leading cardiac surgeon
You may also be interested in...
Intuitive Surgical’s New da Vinci Indications To Grow Sales By 40% In 2005
Expanded indications and premium-priced accessories for Intuitive Surgical's da Vinci robotic surgery system will drive a sales growth of at least 40% to $194 mil. by year-end, according to the company
Cardica’s Pooled Anastomosis Device Data Fail To Connect With FDA Panel
Cardica, Inc.'s PAS Port proximal anastomosis device has appeal as a less invasive alternative to suturing for coronary bypass surgery, but the firm lacks sufficient data to demonstrate safety and effectiveness, FDA's Circulatory System Devices Panel members agreed April 22
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.